Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,215 USD | +5,39% | +6,44% | -83,07% |
23/04 | Transcript : CNS Pharmaceuticals, Inc. - Special Call | |
01/04 | CNS Pharmaceuticals, Inc. rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023 | CI |
Vakgebied
Aantal werknemers: 4
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Climaco
CEO | Chief Executive Officer | 55 | 01-09-17 |
Director of Finance/CFO | 45 | 13-11-19 | |
Sandra Silberman
CTO | Chief Tech/Sci/R&D Officer | 69 | 01-12-17 |
Donald Picker
CTO | Chief Tech/Sci/R&D Officer | 78 | 01-01-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donald Picker
CTO | Chief Tech/Sci/R&D Officer | 78 | 01-01-18 |
John Climaco
CEO | Chief Executive Officer | 55 | 01-09-17 |
Faith Charles
CHM | Chairman | 62 | 03-01-23 |
Jeffry Keyes
BRD | Director/Board Member | 51 | 25-06-18 |
Bettina Cockroft
BRD | Director/Board Member | 57 | 08-05-23 |
Jerzy Gumulka
BRD | Director/Board Member | 75 | 08-11-17 |
Carl Evans
BRD | Director/Board Member | 77 | 09-07-18 |
Amy Mahery
BRD | Director/Board Member | - | 18/01 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 10 634 932 | 9 621 176 ( 90,47 %) | 0 | 90,47 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-83,07% | 2,29 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |
- Beurs
- Aandelen
- Koers CNSP
- Onderneming CNS Pharmaceuticals, Inc.